PolyPid Announces Dikla Czaczkes Akselbrad Assumes Role of CEO

05.07.2022 - Company Previously Announced Planned CEO Transition Following Retirement of Amir WeisbergPETACH TIKVA, Israel, July 05, 2022 (GLOBE NEWSWIRE) - PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to ... Seite 1

Related Keywords

Israel , Dikla Czaczkes Akselbrad , Czaczkes Akselbrad , Jacob Harel , Amir Weisberg , Company Previously Announced Planned , Polypid Ltd , Company Executive Vice , Nasdaq , Following Retirement , Executive Vice President , Chief Financial Officer , Chief Executive Officer , New Drug Application ,